BAX and neoplasm: The apoptotic Bax protein was not altered by the treatment with CrataBL or the peptides, either alone or in combination with chemotherapy, leading us to conclude that the mechanism involved in the effect of these compounds is independent of Bax and related to the reduction in NF-kB p50, causing apoptosis and interfering with tumor growth [33].